Darolutamide for treatment of castration-resistant prostate cancer

Rhea, LP; Mendez-Marti, S; Aragon-Ching, JB

Aragon-Ching, JB (corresponding author), Nova Schar Canc Inst, Genitourinary Canc, 8081 Innovat Pk Dr, Fairfax, VA 22031 USA.

DRUGS OF TODAY, 2020; 56 (3): 185

Abstract

Darolutamide is a novel, nonsteroidal androgen receptor (AR)-signaling inhibitor. It serves as a second-generation antiandrogen and is currently indic......

Full Text Link